Anika Sterilis Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 8.08 Cr
as on 05-07-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.35 Cr
as on 05-07-2024
- Revenue 164.25%
(FY 2023)
- Profit 6.65%
(FY 2023)
- Ebitda -8.40%
(FY 2023)
- Net Worth 105.65%
(FY 2023)
- Total Assets 769.57%
(FY 2023)
About Anika Sterilis
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.08 Cr.
The company has closed loans amounting to ₹5.35 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hemant Kumar and Reetu Sharma serve as directors at the Company.
- CIN/LLPIN
U74999HR2017PTC069695
- Company No.
069695
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Anika Sterilis?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Kumar  | Managing Director | 28-Jun-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Reetu Sharma | Director | 28-Jun-2017 | Current |
Financial Performance of Anika Sterilis.
Anika Sterilis Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 164.25% increase. The company also saw a slight improvement in profitability, with a 6.65% increase in profit. The company's net worth Soared by an impressive increase of 105.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anika Sterilis?
In 2023, Anika Sterilis had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anika Advance Sciences Private LimitedActive 2 years 4 monthsHemant Kumar and Reetu Sharma are mutual person
- Penger Tech India Private LimitedActive 7 years 6 months
Hemant Kumar and Reetu Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 13 Sep 2021 | ₹5.35 Cr | Satisfied |
How Many Employees Work at Anika Sterilis?
Unlock and access historical data on people associated with Anika Sterilis, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anika Sterilis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anika Sterilis's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
